The authority of the first mmwave assisted treatment of COVID-19 published a press conference

        At 9:00 am on September 10, 2020, in the multi-function Hall of the R&D building of Beijing Zhongcheng Kangfu Technology Co., LTD., Fangshan District, Beijing, a press conference was held on the authoritative publication of the medical paper "Clinical Effect of millimeter wave acupoint irradiation in the treatment of Novel Coronavirus Pneumonia" in the Chinese Journal of Hospital Infectiology. Mr. Hou Hao, Chairman of Beijing Zhongcheng Kangfu Technology Co., LTD., Ms. Zhang Xue, Managing director of Beijing Zhongcheng Kangfu Technology Co., LTD., Mr. Lin Zhi, General manager of Marketing Center, Mr. Shan Ziqiang, deputy general manager of Beijing Zhongcheng Kangfu Technology Co., LTD., participated in the press conference, together with leaders of various provinces and regions, as well as nearly 100 media such as "Friends of Health" magazine, Sina.com, Sohu, Zhonghua and Tencent.

        Since the outbreak of the novel coronavirus, information related to the epidemic has always touched the hearts of people across the country. Beijing Zhongcheng Kangfu Technology Co., LTD., together with the Chinese Health Management Association, donated millimeter-wave treatment equipment worth 2 million yuan to the People's Hospital of Hongan County, the General Hospital of the Central Theater of the Chinese People's Liberation Army, Wuhan Huoshenshan and Leishenshan Hospital in the first time, and got good clinical feedback.

Business leaders and major media actively ask questions and exchange

        Combined with the clinical results of conventional treatment of traditional Chinese and Western medicine combined with millimeter wave therapy, the paper Clinical Effect of millimeter wave acupoint Irradiation on Novel Coronavirus Pneumonia, which was studied and written by 12 experts including Professor Ni Jiaxiang, chief expert of Xuanwu Hospital of Capital Medical University, was published in the core journal of Chinese Journal of Hospital Infectiology, volume 30, September issue, 2020.

        Chinese Journal of Nosocomiology, founded in 1991, is a series of journals of the Chinese Medical Association, which is supervised by the General Hospital of the Chinese People's Liberation Army and sponsored by the General Hospital of the Chinese People's Liberation Army and the Chinese Preventive Medicine Association.

        The successful publication of this paper indicates that Nakasari has taken another step forward in the fight against the epidemic. This paper also fills the clinical gap of millimeter wave therapy in the treatment of novel coronavirus pneumonia, which is of great significance for the treatment of novel coronavirus pneumonia, and provides an effective auxiliary treatment plan for the current fight against the epidemic. It has a good reference role.

Beijing Zhongcheng Kangfu Technology Co., LTD

Mr. Hou Hao, chairman of the board, delivered a speech at the conference

          Mr. Hou Hao, chairman of Beijing Zhongcheng Kangfu Technology Co., LTD., pointed out in his speech at the event that China has faced the COVID-19 epidemic, taken the most comprehensive, strict and thorough prevention and control measures, and achieved sustained and good results in a relatively short period of time. At present, millimeter wave acupoint irradiation for the treatment of novel coronavirus pneumonia has achieved good results on clinical data, and the advent of this achievement has brought the pace of global anti-epidemic into a new track. Using the special biological effect of millimeter wave to transform the function, it not only enhances the antioxidant capacity of human cells, but also delays cell senescence; It also increases the activity of immune cells, improves the ability of the human body to overcome disease, and effectively protects against the invasion of germs. Thus, it is applied to the physiological functions of various systems, viscera, organ tissues and metabolism in modern medicine, which will indicate the direction of modern medicine in disease treatment and will eventually become a breakthrough in modern medicine in the world.

Beijing Zhongcheng Kangfu Technology Co., LTD

Ms. Zhang Xue, Managing Director, spoke at the launch

         Ms. Zhang Xue, managing director of Beijing Zhongcheng Kangfu Technology Co., LTD., said at the event that in the early days of the epidemic, Professor Ni Jiaxiang, chief expert of Xuanwu Hospital of Capital Medical University, and more than 60 medical workers put forward a proposal report to the Central anti-epidemic Leading Group on adding "millimeter wave radiation and acupoint therapy" to the treatment of novel coronavirus pneumonia.At the same time, this therapy was applied to the clinical treatment of COVID-19. Through 47 patients with COVID-19, the conventional treatment of traditional Chinese and western medicine combined with millimeter-wave therapy achieved good clinical effect, which provided a new treatment mode for the combined treatment of COVID-19. At the same time, Mr. Shao Kairong, who is a politician, diplomat, entrepreneur, outstanding social activist and outstanding international community leader, said in an interview with a reporter from the News of Macao that the use of millimeter wave combined with the "acupoint therapy" in the culture of traditional Chinese medicine can wake up sleeping human cells and enhance their immune ability, calling for the attention and attention of relevant national leaders.

Mr. Shao Kailong was interviewed by the reporter of Macau News

        The atmosphere at the event was rich, and the audience and the major media actively asked questions and exchanges. With the successful publication of the medical paper "The Clinical Effect of millimeter wave acupoint Irradiation in the Treatment of Novel Coronavirus Pneumonia", millimeter wave therapy has once again been clinically verified, and mankind has another weapon to fight against the new coronavirus epidemic!

        Since its establishment in 2004, Beijing Zhongcheng Kangfu Technology Co., Ltd. has been devoted to the research and development of millimeter wave technology in the medical field for 16 years under the beautiful vision of "science and technology serve life, medical treatment change people's livelihood" mission, and strive to promote the technological achievements from medical to civilian transformation process. At present, "100 millimeter wave" has been included in the medical insurance reimbursement catalog and entered the country's major three hospitals, "three, two, one, community hospitals" nearly more than 5,000. The total number of users has exceeded 20 million, forming a win-win situation for the government, enterprises, hospitals and patients. As a model enterprise in the capital medical manufacturing industry, Zhongcheng Kangfu undertook the national project of establishing millimeter wave clinical research bases in 50 large first-class hospitals across the country, and was honored with the name of "100 Full millimeter Wave Clinical Research Base".

       Beijing Zhongcheng Kangfu Technology Co., LTD., from the scientific research laboratory to the third class clinical, from the third class hospital to the community medical center, from the community medical treatment to thousands of households, where there is a slow disease where there is a hundred, where there is an epidemic, where there is millimeter wave. Millimeter wave as a new treatment technology, although in China's medical and health industry has achieved fruitful results, but Zhongcheng Kangfu will not forget the original heart to forge ahead, vowed to millimeter wave equipment home to the end!